comparemela.com

Latest Breaking News On - Seth wander - Page 1 : comparemela.com

Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024

COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC)

Dana farber cancer instituteUnited statesDsenthil damodaranSimon jenkinsPaul plourdeElizabeth attiasDavid portmanBarry kommMiriam portmanHarvard medical schoolParke davis pharmaceuticalsUniversity of miamiSermonix pharmaceuticals incPhd md anderson cancer centerHospital cancer centerPhd harvard medical school

Dr Wander on Genomic Alterations in ER+/HER2– Metastatic Breast Cancer

Seth Wander, MD, PhD, discusses findings from an analysis of baseline genomic alterations in patients with estrogen receptor–positive, HER2-negative metastatic breast cancer who were enrolled in the single-arm, phase 2 ELAINE-2 trial of lasofoxifene plus abemaciclib.

United statesHarvard medical schoolSeth wanderMassachusetts general hospitalPatients with estrogen receptor positiveEr2 negative metastatic breast cancerElaine 2 trialLasofoxifene plus abemaciclib

Combination Shows Promise in Metastatic ESR1-Mutant Breast Cancer

Durable responses with lasofoxifene plus abemaciclib in post-CDK4/6 inhibitor setting

United statesMayo clinic in rochesterMatthew goetzDsenthil damodaranCharles bankheadUniversity of texas md anderson cancer centerHarvard medical schoolCancer centerMayo clinicSeth wanderMassachusetts general hospitalMedpage today

Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy

/PRNewswire/ Regor Therapeutics Group ("Regor"), a global innovator powered by cutting-edge drug discovery engine and differentiated clinical development.

United statesSan antonioPrnewswire regor therapeutics groupRegor therapeutics groupFirst in human phaseTherapeutics groupSeth wanderMassachusetts general hospitalSan antonio breast cancer symposiumChief executive officerRegor therapeuticsComputer accelerated rational discovery

Expert Insights on the United States Chemotherapy Shortage

Oncology experts discuss the platinum chemotherapy shortage in the United States.

Mayo clinic in rochesterUnited statesDana farber cancer instituteNew havenYale schoolDanielp petrylakPaolo tarantinoEdgardo santosLionela kankeu fonkouaSolange petersAshling wahnerNational comprehensive cancer networkGenitourinary oncology at yale cancer centerThoracic malignancies programmeUniversity hospital of lausanneHarvard medical school

vimarsana © 2020. All Rights Reserved.